Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.

<h4>Objective</h4>To assess the availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.<h4>Methods</h4>A cross-sectional survey involving 27 private pharmacies, 13 public pharmacies, and 25 private hospital pharmacies in Abu...

Full description

Bibliographic Details
Main Authors: Nkeiruka Grace Osuafor, Chinwe Victoria Ukwe, Mathew Okonta
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0255567
id doaj-7f6076a3b6ed49e293756bea6ddb2124
record_format Article
spelling doaj-7f6076a3b6ed49e293756bea6ddb21242021-08-17T04:30:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01168e025556710.1371/journal.pone.0255567Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.Nkeiruka Grace OsuaforChinwe Victoria UkweMathew Okonta<h4>Objective</h4>To assess the availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.<h4>Methods</h4>A cross-sectional survey involving 27 private pharmacies, 13 public pharmacies, and 25 private hospital pharmacies in Abuja was conducted using the standardized World Health Organization/Health Action International methodology. The availability percentage for each pharmacy sector and each medicine was analyzed. The median price ratio (MPR) (ratio of the median price to the international reference prices) of the medicines were evaluated accordingly. Affordability was assessed by calculating the number of days' wages the lowest-paid unskilled government worker required to purchase a month worth of the standard treatment for a chronic condition.<h4>Results</h4>The availability of cardiovascular (CV) medicines ranged from 28.4% (in private hospital pharmacies) to 59.9% (in private pharmacies). There was mixed variability in the mean availability of Originator Brands (OBs) and Lowest Priced Generics (LPGs) anti-diabetic drugs with the highest availability being OBs 36% and LPGs 40.2%, in private pharmacies and public pharmacies, respectively. The availability of global drugs ranged from 49.7% in private hospitals to 68.8% in private pharmacies. Two cardiovascular and four global medicines had greater than 80% availability across the pharmaceutical sectors. The median price ratio for OBs and LPGs was 9.60 and 1.72 for procurement, it was 8.08 and 2.60 in private pharmacies, 13.56 and 2.66 in public hospitals, and 16.38 and 7.89 in private hospitals. The percentage markup on LPG was 49.4% in public hospitals, 51.4% in private pharmacies, and 323% in private hospitals. Only nine medicines in both public hospitals and private pharmacies and two in the private hospital pharmacies required less than the daily wage of the lowest-paid government worker.<h4>Conclusion</h4>The availability of cardiovascular, diabetes, and global medicines was below 80% across the different pharmaceutical sectors in Abuja and the medicines were unaffordable. Although the prices were generally exorbitant, private pharmacies offered the best options in terms of availability, pricing, and affordability of medicines. Therefore, the results of this study emphasize the pertinence of enforcing policies that facilitate the availability, pricing, and affordability of cardiovascular, diabetes, and global medicines.https://doi.org/10.1371/journal.pone.0255567
collection DOAJ
language English
format Article
sources DOAJ
author Nkeiruka Grace Osuafor
Chinwe Victoria Ukwe
Mathew Okonta
spellingShingle Nkeiruka Grace Osuafor
Chinwe Victoria Ukwe
Mathew Okonta
Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
PLoS ONE
author_facet Nkeiruka Grace Osuafor
Chinwe Victoria Ukwe
Mathew Okonta
author_sort Nkeiruka Grace Osuafor
title Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
title_short Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
title_full Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
title_fullStr Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
title_full_unstemmed Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
title_sort evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in abuja, nigeria.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description <h4>Objective</h4>To assess the availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.<h4>Methods</h4>A cross-sectional survey involving 27 private pharmacies, 13 public pharmacies, and 25 private hospital pharmacies in Abuja was conducted using the standardized World Health Organization/Health Action International methodology. The availability percentage for each pharmacy sector and each medicine was analyzed. The median price ratio (MPR) (ratio of the median price to the international reference prices) of the medicines were evaluated accordingly. Affordability was assessed by calculating the number of days' wages the lowest-paid unskilled government worker required to purchase a month worth of the standard treatment for a chronic condition.<h4>Results</h4>The availability of cardiovascular (CV) medicines ranged from 28.4% (in private hospital pharmacies) to 59.9% (in private pharmacies). There was mixed variability in the mean availability of Originator Brands (OBs) and Lowest Priced Generics (LPGs) anti-diabetic drugs with the highest availability being OBs 36% and LPGs 40.2%, in private pharmacies and public pharmacies, respectively. The availability of global drugs ranged from 49.7% in private hospitals to 68.8% in private pharmacies. Two cardiovascular and four global medicines had greater than 80% availability across the pharmaceutical sectors. The median price ratio for OBs and LPGs was 9.60 and 1.72 for procurement, it was 8.08 and 2.60 in private pharmacies, 13.56 and 2.66 in public hospitals, and 16.38 and 7.89 in private hospitals. The percentage markup on LPG was 49.4% in public hospitals, 51.4% in private pharmacies, and 323% in private hospitals. Only nine medicines in both public hospitals and private pharmacies and two in the private hospital pharmacies required less than the daily wage of the lowest-paid government worker.<h4>Conclusion</h4>The availability of cardiovascular, diabetes, and global medicines was below 80% across the different pharmaceutical sectors in Abuja and the medicines were unaffordable. Although the prices were generally exorbitant, private pharmacies offered the best options in terms of availability, pricing, and affordability of medicines. Therefore, the results of this study emphasize the pertinence of enforcing policies that facilitate the availability, pricing, and affordability of cardiovascular, diabetes, and global medicines.
url https://doi.org/10.1371/journal.pone.0255567
work_keys_str_mv AT nkeirukagraceosuafor evaluationofavailabilitypriceandaffordabilityofcardiovasculardiabetesandglobalmedicinesinabujanigeria
AT chinwevictoriaukwe evaluationofavailabilitypriceandaffordabilityofcardiovasculardiabetesandglobalmedicinesinabujanigeria
AT mathewokonta evaluationofavailabilitypriceandaffordabilityofcardiovasculardiabetesandglobalmedicinesinabujanigeria
_version_ 1721205548430393344